111 299

Cited 1 times in

Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report

DC Field Value Language
dc.contributor.author유성환-
dc.contributor.author이관식-
dc.contributor.author이정일-
dc.contributor.author이현웅-
dc.contributor.author임진홍-
dc.date.accessioned2022-05-09T17:08:14Z-
dc.date.available2022-05-09T17:08:14Z-
dc.date.issued2022-03-
dc.identifier.issn2288-8128-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/188398-
dc.description.abstractThere are various methods for treating advanced hepatocellular carcinoma with portal vein invasion, such as systemic chemotherapy, transarterial chemoembolization, transarterial radioembolization, and concurrent chemoradiotherapy. These methods have similar clinical efficacy but are designed with a palliative aim. Herein, we report a case that experienced complete remission through “associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)” after concurrent chemoradiotherapy and hepatic artery infusion chemotherapy. In this patient, concurrent chemoradiotherapy and hepatic artery infusion chemotherapy induced substantial tumor shrinkage, and hypertrophy of the nontumor liver was sufficiently induced by portal vein ligation (stage 1 surgery) followed by curative resection (stage 2 surgery). Using this approach, long-term survival with no evidence of recurrence was achieved at 16 months. Therefore, the optimal use of ALPPS requires sufficient consideration in cases of significant hepatocellular carcinoma shrinkage for curative purposes.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageKorean-
dc.publisher대한간암학회-
dc.relation.isPartOfJournal of Liver Cancer(대한간암학회지)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleLong-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorIn-Jung Kim-
dc.contributor.googleauthorSung Hwan Yoo-
dc.contributor.googleauthorJung Il Lee-
dc.contributor.googleauthorKwan Sik Lee-
dc.contributor.googleauthorHyun Woong Lee-
dc.contributor.googleauthorJin Hong Lim-
dc.identifier.doi10.17998/jlc.2022.03.07-
dc.contributor.localIdA05883-
dc.contributor.localIdA02666-
dc.contributor.localIdA03122-
dc.contributor.localIdA03292-
dc.relation.journalcodeJ03078-
dc.identifier.eissn2383-5001-
dc.subject.keywordCarcinoma-
dc.subject.keywordhepatocellular-
dc.subject.keywordPortal vein-
dc.subject.keywordHepatectomy-
dc.subject.keywordConcurrent chemoradiotherapy-
dc.subject.keywordCase reports-
dc.contributor.alternativeNameYoo, Sung Hwan-
dc.contributor.affiliatedAuthor유성환-
dc.contributor.affiliatedAuthor이관식-
dc.contributor.affiliatedAuthor이정일-
dc.contributor.affiliatedAuthor이현웅-
dc.citation.volume22-
dc.citation.number1-
dc.citation.startPage84-
dc.citation.endPage90-
dc.identifier.bibliographicCitationJournal of Liver Cancer(대한간암학회지), Vol.22(1) : 84-90, 2022-03-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.